US EditionDEA Cannabis Bias Confirmed? How This Hurts Rescheduling
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
DEA Cannabis Bias Confirmed? How This Hurts Rescheduling
On the latest Trade to Black podcast for March 10, 2025, hosts Shadd Dales and Anthony Varrell are joined by Shane Pennington, who will discuss the big news involving the US Drug Enforcement Administration’s (DEA) stance on marijuana rescheduling and an accusation of bias. Shane Pennington is a Partner at Porter Wright Morris & Arthur LLP. Plus, Michael Bronstein from the American Trade Association for Cannabis & Hemp will join us to discuss sev…
Suspicions that DEA rigged rescheduling process fueled by court documents
Longstanding suspicions that the U.S. Drug Enforcement Administration is adamantly opposed to marijuana rescheduling – and weighted a public process to ensure it could reject moving the drug from Schedule 1 to Schedule 3 under federal law – are confirmed by agency decisions made public during an ongoing lawsuit. At least, that’s the allegation made in a Feb. 17 federal court filing by a group of doctors who were shut out of the rescheduling proc…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
